Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Npj Drug Discovery
|
April 6, 2026
Large animal models for the assessment of snakebite envenoming therapies
Melisa Benard-Valle, Shirin Ahmadi, Cassandra M Modahl, et al.
Npj Drug Discovery
|
June 30, 2026
Structure and dynamics in drug discovery
Haixin Wei, J Andrew McCammon
Npj Drug Discovery
|
June 30, 2026
Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration
Rebecca R Leahey, Martin Weber, Chang Hoon Cho, et al.
Npj Drug Discovery
|
June 30, 2026
SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses
Anisha Mani, Mateusz Mendel, Paul Westwood, et al.
Npj Drug Discovery
|
July 1, 2026
Mechanisms that matter: unbiased cellular screening for degraders
Helen E Burston, Elizabeth M Rosethorne, Francesca Cavallo, et al.
Npj Drug Discovery
|
June 30, 2026
Integrating artificial intelligence into small molecule development for precision cancer immunomodulation therapy
Henry Sutanto, Deasy Fetarayani
Npj Drug Discovery
|
April 13, 2026
Accelerating GPCR drug discovery through computation and experiment integrated with direct detection of ligand binding events
Judith Su, Stephen B Liggett, Soo-Kyung Kim, et al.
Npj Drug Discovery
|
April 6, 2026
A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations
Harkirat Singh Arora, Katherine Lev, Aaron Robida, et al.
Npj Drug Discovery
|
July 1, 2026
Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function
Samuel L Murphy, Wai Hong Wilson Tang, Xiaolei Zhuang, et al.
Npj Drug Discovery
|
July 1, 2026
An online GPCR drug discovery resource
Jimmy Caroli, Søren N Andreassen, Javier Sánchez Lorente, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Npj Drug Discovery
|
April 6, 2026
Large animal models for the assessment of snakebite envenoming therapies
Melisa Benard-Valle, Shirin Ahmadi, Cassandra M Modahl, et al.
Npj Drug Discovery
|
June 30, 2026
Structure and dynamics in drug discovery
Haixin Wei, J Andrew McCammon
Npj Drug Discovery
|
June 30, 2026
Therapeutic safety implications of SARM1 active site inhibitors: subinhibitory concentrations cause neurodegeneration
Rebecca R Leahey, Martin Weber, Chang Hoon Cho, et al.
Npj Drug Discovery
|
June 30, 2026
SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses
Anisha Mani, Mateusz Mendel, Paul Westwood, et al.
Npj Drug Discovery
|
July 1, 2026
Mechanisms that matter: unbiased cellular screening for degraders
Helen E Burston, Elizabeth M Rosethorne, Francesca Cavallo, et al.
Npj Drug Discovery
|
June 30, 2026
Integrating artificial intelligence into small molecule development for precision cancer immunomodulation therapy
Henry Sutanto, Deasy Fetarayani
Npj Drug Discovery
|
April 13, 2026
Accelerating GPCR drug discovery through computation and experiment integrated with direct detection of ligand binding events
Judith Su, Stephen B Liggett, Soo-Kyung Kim, et al.
Npj Drug Discovery
|
April 6, 2026
A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations
Harkirat Singh Arora, Katherine Lev, Aaron Robida, et al.
Npj Drug Discovery
|
July 1, 2026
Preferential HER4 stimulation preserves neuregulin-induced improvement of myocardial function
Samuel L Murphy, Wai Hong Wilson Tang, Xiaolei Zhuang, et al.
Npj Drug Discovery
|
July 1, 2026
An online GPCR drug discovery resource
Jimmy Caroli, Søren N Andreassen, Javier Sánchez Lorente, et al.
Page
of 5